Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 3 Neoplasms 2 Colorectal Neoplasms 2 Rectal Neoplasms 1 Esophageal Neoplasms 1 Epilepsy 1 Carcinoma, Transitional Cell 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Lobular 1

Interventions

LY3295668 erbumine 2 Everolimus 2 ziprasidone 1 enzalutamide 1 clevidipine 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tranexamic Acid 1 Tobramycin 1 Spironolactone 1 Sirolimus 1 Sevoflurane 1 Sevelamer 1 Saline Solution 1 Rocuronium 1 Propofol 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nitrous Oxide 1 Nifedipine 1 Nafcillin 1 Molindone 1 Midazolam 1 Methylprednisolone 1 Mass Screening 1 Lurasidone Hydrochloride 1 Lidocaine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Epilepsy × Histocompatibility Testing × Clear all

NCT00152659 2023-04-26

Developing Criteria for Cortical Resections

University of Chicago

Epilepsy, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡